Observer-Blind Randomized Control Trial for the Effectiveness of Intensive Case Management in Seoul: Clinical and Quality-of-Life Outcomes for Severe Mental Illness.

IF 1.8 4区 医学 Q3 PSYCHIATRY
Psychiatry Investigation Pub Date : 2025-05-01 Epub Date: 2025-05-15 DOI:10.30773/pi.2024.0340
Hye-Young Min, Seung-Hee Ahn, Jeung Suk Lim, Hwa Yeon Seo, Sung Joon Cho, Seung Yeon Lee, Dohhee Kim, Kihoon You, Hyun Seo Choi, Su-Jin Yang, Jee Eun Park, Bong Jin Hahm, Hae Woo Lee, Jee Hoon Sohn
{"title":"Observer-Blind Randomized Control Trial for the Effectiveness of Intensive Case Management in Seoul: Clinical and Quality-of-Life Outcomes for Severe Mental Illness.","authors":"Hye-Young Min, Seung-Hee Ahn, Jeung Suk Lim, Hwa Yeon Seo, Sung Joon Cho, Seung Yeon Lee, Dohhee Kim, Kihoon You, Hyun Seo Choi, Su-Jin Yang, Jee Eun Park, Bong Jin Hahm, Hae Woo Lee, Jee Hoon Sohn","doi":"10.30773/pi.2024.0340","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>In South Korea, there is a significant gap in systematic, evidence-based research on intensive case management (ICM) for individuals with severe mental illness (SMI). This study aims to evaluate the effectiveness of ICM through a randomized controlled trial (RCT) comparing ICM with standard case management (non-ICM).</p><p><strong>Methods: </strong>An RCT was conducted to assess the effectiveness of Seoul-intensive case management (S-ICM) vs. non-ICM in individuals with SMI in Seoul. A total of 78 participants were randomly assigned to either the S-ICM group (n=41) or the control group (n=37). Various clinical assessments, including the Brief Psychiatric Rating Scale (BPRS), Montgomery-Åsberg Depression Rating Scale, Health of the Nation Outcome Scale, and Clinical Global Impression-Improvement (CGI-I), along with quality-of-life measures such as the WHO Disability Assessment Schedule, WHO Quality of Life scale, and Multidimensional Scale of Perceived Social Support (MSPSS) were evaluated over a 3-month period. Statistical analyses, including analysis of covariance and logistic regression, were used to determine the effectiveness of S-ICM.</p><p><strong>Results: </strong>The S-ICM group had significantly lower odds of self-harm or suicidal attempts compared to the control group (adjusted odds ratio [aOR]=0.30, 95% confidence interval [CI]: 0.21-1.38). Psychiatric symptoms measured by the BPRS and perceived social support measured by the MSPSS significantly improved in the S-ICM group. The S-ICM group also had significantly higher odds of CGI-I compared to the control group (aOR=8.20, 95% CI: 2.66-25.32).</p><p><strong>Conclusion: </strong>This study provides inaugural evidence on the effectiveness of S-ICM services, supporting their standardization and potential nationwide expansion.</p>","PeriodicalId":21164,"journal":{"name":"Psychiatry Investigation","volume":"22 5","pages":"513-521"},"PeriodicalIF":1.8000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12104754/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.30773/pi.2024.0340","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: In South Korea, there is a significant gap in systematic, evidence-based research on intensive case management (ICM) for individuals with severe mental illness (SMI). This study aims to evaluate the effectiveness of ICM through a randomized controlled trial (RCT) comparing ICM with standard case management (non-ICM).

Methods: An RCT was conducted to assess the effectiveness of Seoul-intensive case management (S-ICM) vs. non-ICM in individuals with SMI in Seoul. A total of 78 participants were randomly assigned to either the S-ICM group (n=41) or the control group (n=37). Various clinical assessments, including the Brief Psychiatric Rating Scale (BPRS), Montgomery-Åsberg Depression Rating Scale, Health of the Nation Outcome Scale, and Clinical Global Impression-Improvement (CGI-I), along with quality-of-life measures such as the WHO Disability Assessment Schedule, WHO Quality of Life scale, and Multidimensional Scale of Perceived Social Support (MSPSS) were evaluated over a 3-month period. Statistical analyses, including analysis of covariance and logistic regression, were used to determine the effectiveness of S-ICM.

Results: The S-ICM group had significantly lower odds of self-harm or suicidal attempts compared to the control group (adjusted odds ratio [aOR]=0.30, 95% confidence interval [CI]: 0.21-1.38). Psychiatric symptoms measured by the BPRS and perceived social support measured by the MSPSS significantly improved in the S-ICM group. The S-ICM group also had significantly higher odds of CGI-I compared to the control group (aOR=8.20, 95% CI: 2.66-25.32).

Conclusion: This study provides inaugural evidence on the effectiveness of S-ICM services, supporting their standardization and potential nationwide expansion.

首尔强化病例管理有效性的观察者盲随机对照试验:重度精神疾病的临床和生活质量结局。
目的:在韩国,严重精神疾病(SMI)患者的强化病例管理(ICM)的系统性、循证研究存在显著差距。本研究旨在通过一项比较ICM与标准病例管理(非ICM)的随机对照试验(RCT)来评估ICM的有效性。方法:通过一项随机对照试验来评估首尔密集病例管理(S-ICM)与非icm在首尔重度精神分裂症患者中的有效性。共有78名参与者被随机分配到S-ICM组(n=41)或对照组(n=37)。各种临床评估,包括简短精神病学评定量表(BPRS)、Montgomery-Åsberg抑郁评定量表、国家健康结果量表和临床总体印象改善量表(CGI-I),以及生活质量测量,如WHO残疾评估表、WHO生活质量量表和多维感知社会支持量表(MSPSS),在三个月的时间内进行了评估。统计分析包括协方差分析和逻辑回归分析,以确定S-ICM的有效性。结果:S-ICM组自我伤害或自杀企图的几率明显低于对照组(校正优势比[aOR]=0.30, 95%可信区间[CI]: 0.21-1.38)。S-ICM组以BPRS测量的精神症状和MSPSS测量的感知社会支持显著改善。S-ICM组发生CGI-I的几率也明显高于对照组(aOR=8.20, 95% CI: 2.66-25.32)。结论:本研究为S-ICM服务的有效性提供了初步证据,支持其标准化和全国推广的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
3.70%
发文量
105
审稿时长
6-12 weeks
期刊介绍: The Psychiatry Investigation is published on the 25th day of every month in English by the Korean Neuropsychiatric Association (KNPA). The Journal covers the whole range of psychiatry and neuroscience. Both basic and clinical contributions are encouraged from all disciplines and research areas relevant to the pathophysiology and management of neuropsychiatric disorders and symptoms, as well as researches related to cross cultural psychiatry and ethnic issues in psychiatry. The Journal publishes editorials, review articles, original articles, brief reports, viewpoints and correspondences. All research articles are peer reviewed. Contributions are accepted for publication on the condition that their substance has not been published or submitted for publication elsewhere. Authors submitting papers to the Journal (serially or otherwise) with a common theme or using data derived from the same sample (or a subset thereof) must send details of all relevant previous publications and simultaneous submissions. The Journal is not responsible for statements made by contributors. Material in the Journal does not necessarily reflect the views of the Editor or of the KNPA. Manuscripts accepted for publication are copy-edited to improve readability and to ensure conformity with house style.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信